Quecitinib - CAS 2416858-84-7

Quecitinib (QY201) is an orally active dual inhibitor of JAK1/TYK2. It acts as a substrate for cytochrome P450 3A, predominantly metabolized into mono-oxidized and glucuronidated products. Quecitinib demonstrates favorable pharmacokinetic properties and safety. It is applicable for research on atopic dermatitis and other autoimmune diseases.

JAK, Cytochromes P450

Tyrosine Kinase/Adaptors, Angiogenesis, Chromatin/Epigenetic, JAK/STAT signaling, Stem Cells, Metabolism

2416767

C17H20N6O

324.38

[C@H](C)(O)C=1N(C2=C3C(NC=C2N1)=NC=C3)N4CCC(CC#N)CC4

-20°C

Ice Packs

Small Compound